特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
928818

北米の遺伝子検査サービス市場 - タイプ・疾患・サービスプロバイダー・国別の市場分析と予測

North America Genetic Testing Services Market to 2027 - Regional Analysis and Forecasts by Type, Disease, Service Provider and Country

出版日: | 発行: The Insight Partners | ページ情報: 英文 172 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.15円
北米の遺伝子検査サービス市場 - タイプ・疾患・サービスプロバイダー・国別の市場分析と予測
出版日: 2020年02月28日
発行: The Insight Partners
ページ情報: 英文 172 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

北米の遺伝子検査サービスの市場規模は、2019年に30億4,440万米ドル規模と評価され、2020年から2027年にかけては12.1%のCAGRで推移し、74億600万米ドル規模の市場に成長すると予測されています。遺伝子疾患の有病率の上昇や、個別化医療の普及および認知度の向上、消費者直結型(DTC)遺伝子検査サービスに対する選好の高まりなどによって当市場の成長が促進されています。

当レポートでは、北米の遺伝子検査サービス市場を調査し、市場の概要、タイプ・疾患・サービスプロバイダー・国別の市場規模の推移と予測、市場シェア、収益予測、市場の成長要因および阻害要因の分析、市場機会、競合情勢、主要企業のプロファイルなど、包括的な情報を提供しています。

目次

第1章 イントロダクション

  • 調査範囲
  • The Insight Partners調査ガイダンス

第2章 重要点

第3章 市場情勢

  • 概要
  • 市場セグメンテーション
  • PEST分析
  • 専門家の意見

第4章 市場力学

  • 主な成長要因
  • 主な阻害要因
  • 遺伝子検査の社会的および倫理的影響
  • 主要な市場機会
  • 今後の動向
  • 成長要因と阻害要因の影響分析

第5章 北米の遺伝子検査サービス市場の分析

  • 北米の遺伝子検査サービス市場の収益予測と分析
  • 市場ポジショニング
  • 主要企業のパフォーマンス

第6章 北米の遺伝子検査サービス市場:タイプ別

  • 概要
  • 市場シェア:タイプ別(実績値・予測値)
  • 収益予測:タイプ別
  • 新生児スクリーニング
  • 出生前検査
  • 予測的遺伝子検査
  • キャリアテスト
  • その他

第7章 北米の遺伝子検査サービス市場:疾患別

  • 概要
  • 市場シェア:疾患別(実績値・予測値)
  • 収益予測:疾患別
  • がん
  • 代謝性疾患
  • 心血管疾患
  • その他

第8章 北米の遺伝子検査サービス市場:サービスプロバイダー別

  • 概要
  • 市場シェア:サービスプロバイダー別(実績値・予測値)
  • 収益予測:疾患別
  • 診断研究所
  • 病院内研究所
  • 診療所

第9章 北米の遺伝子検査サービス市場:国別

  • 概要
  • 市場シェア:国別

第10章 業界情勢

  • 概要
  • 成長戦略
  • 有機開発
  • 無機開発

第11章 企業プロファイル

  • Laboratory Corporation of America Holdings
  • F. HOFFMANN-LA ROCHE LTD
  • Illumina, Inc.
  • Quest Diagnostics Incorporated
  • Exact Sciences Corporation
  • NeoGenomics Laboratories, Inc.
  • Eurofins Scientific
  • Ambry Genetics
  • Centogene AG
  • andMe, Inc.
  • THERMO FISHER SCIENTIFIC INC.

第12章 付録

  • The Insight Partnersについて
  • 用語集
  • 調査手法
図表

LIST OF TABLES

  • Table 1. North America Genetic Testing Services market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 2. North America Genetic Testing Services market Revenue And Forecasts to 2027, By Disease (US$ Mn)
  • Table 3. North America Genetic Testing Services market Revenue And Forecasts to 2027, By disease (US$ Mn)
  • Table 4. US Genetic Testing Services market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 5. US Genetic Testing Services market Revenue And Forecasts to 2027, By Disease (US$ Mn)
  • Table 6. US Genetic Testing Services Market, Revenue and Forecast To 2027, by Service Provider (US$ Mn)
  • Table 7. Canada Genetic Testing Services market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 8. Canada Genetic Testing Services market Revenue And Forecasts to 2027, By Disease (US$ Mn)
  • Table 9. Canada Genetic Testing Services market Revenue And Forecasts to 2027, By Service Provider (US$ Mn)
  • Table 10. Mexico Genetic Testing Services market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 11. Mexico Genetic Testing Services market Revenue And Forecasts to 2027, By Disease (US$ Mn)
  • Table 12. Mexico Genetic Testing Services market Revenue And Forecasts to 2027, By Service Provider (US$ Mn)
  • Table 13. Recent Organic Growth Strategies In The Genetic Testing Services Market
  • Table 14. Recent Inorganic Growth Strategies In The Genetic Testing Services Market
  • Table 15. Glossary of Terms, Genetic Testing Services market

LIST OF FIGURES

  • Figure 1. US Genetic Testing Services Market, Revenue (US$ Mn), By 2019 & 2027
  • Figure 2. North America Genetic Testing Services Market By Type , Market Share (%), 2019
  • Figure 3. North America Genetic Testing Services Market By Disease, Market Share (%), 2019
  • Figure 4. North America Genetic Testing Services Market By Service Provider, Market Share (%), 2019
  • Figure 5. Genetic Testing Services Market Segmentation
  • Figure 6. North America PEST Analysis
  • Figure 7. Genetic Testing Services Market Impact Analysis Of Driver And Restraint
  • Figure 8. North America Genetic Testing Services Market - Revenue Forecasts And Analysis - 2019- 2027
  • Figure 9. North America Genetic Testing Services Market By Type, 2019 & 2027 (%)
  • Figure 10. New-born Screening Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 11. Prenatal Testing Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 12. Predictive Testing Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 13. Carrier Testing Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 14. Other Testing's Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 15. North America Genetic Testing Services Market By Disease, 2019 & 2027 (%)
  • Figure 16. Cancer Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 17. Metabolic Disease Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 18. Cardiovascular Disease Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 19. Other Diseases Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 20. North America Genetic Testing Services Market By Service Provider, 2019 & 2027 (%)
  • Figure 21. Diagnostic Laboratories Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 22. Hospital-Based Laboratories Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 23. Clinics Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 24. North America Genetic Testing Services Market REVENUE, By Country, 2019 (US$ MN)
  • Figure 25. North America Genetic Testing Services Market Revenue And Forecasts To 2027, By Country (%)
  • Figure 26. US Genetic Testing Services Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 27. Canada Genetic Testing Services Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 28. Mexico Genetic Testing Services Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 29. Growth Strategies In The Genetic Testing Services Market, 2017-2020
目次
Product Code: TIPRE00009262

The North America genetic testing services market is expected to reach US$ 7,406.0 Mn in 2027 from US$ 3,044.4 Mn in 2019. The genetic testing services market is anticipated to grow at a growth rate of 12.1% from 2020-2027.

The factors driving the growth of genetic testing service include rising prevalence of the genetic diseases and rise in awareness & acceptance of personalized medicines. Also, growing preference towards Direct-To-Consumer (DTC) genetic testing, support of government to adopt genetic testing services is positively impacting the growth of the market in the review period. In addition, various strategic initiatives by the manufacturers, new product launch along with artificial intelligence (AI) powered genetic testing is likely to boost the growth of market.

Moreover, increasing focus on advanced method incorporation in healthcare, government and private initiatives for promotion of precision medicine and massive funds from government and private bodies for genetic research is further expected stimulate the growth and contribute to exceptional revenue generation for the genetic testing services market in North America.

The demand for genetic testing in the United States has been expected to witness growth, since the service encompasses a broad range of applications such as, cancer, autoimmune diseases and infectious diseases. In US, the products for genetic testing of pediatric as well as rare diseases has increased significantly. As per the estimates of National Institutes of Health (NIH), in the United States, there are around 25 to 30 million people suffering from rare diseases, accounting for individuals fewer than 200,000 people. Rare diseases are often the result of a genetic mutation; one estimate is that 80% of rare diseases are genetic in nature. Also, 50% of patients with rare diseases are children.

There has been a significant rise in the cases of rare diseases in US during the last decade. In 2009, there were 5,857 catalogued rare disorders, whereas 6,084 number of rare diseases were recorded in 2016, accounting a rate of approximately 30 new rare diseases per year.

Thus the increasing funds and awareness in North America are likely to boost the genetic testing services market and are anticipated to provide significant growth opportunities to the players operating in the market during the forecast period.

The above-mentioned factors are expected to offer broad growth opportunities in the industry, and this is expected to cause the demand for genetic testing services.

North America genetic testing services market is segmented by type, disease, and service provider. Based on the type, the market is segmented into predictive testing, carrier testing, prenatal testing, newborn screening and others. On the basis of disease, the market is classified as, cancer disease, metabolic diseases, cardiovascular diseases and others. Based on service provider, the market is categorized as, diagnostic laboratories, hospital-based laboratories and clinics.

Some of the major primary and secondary sources for genetic testing services market included in the report are World Health Organization (WHO), Clinical Laboratory Improvement Amendments (CLIA), National Institutes of Health (NIH), the North American Cancer Information System among others.

Reasons to Buy

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the genetic testing services market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the North America genetic testing services market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth North America market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table of Contents

1. Introduction

  • 1.1 Scope Of The Study
  • 1.2 The Insight Partners Research Report Guidance

2. North America Genetic Testing Services Market - Key Takeaways

3. North America Genetic Testing Services Market - Market Landscape

  • 3.1 Overview
  • 3.2 Market Segmentation
    • 3.2.1 North America Genetic Testing Services Market - By Type
    • 3.2.2 North America Genetic Testing Services Market - By Disease
    • 3.2.3 North America Genetic Testing Services Market - By Service Provider
    • 3.2.4 North America Genetic Testing Services Market - By Country
  • 3.3 PEST Analysis
  • 3.4 Expert Opinions

4. North America Genetic Testing Services Market-Key Market Dynamics

  • 4.1 Key Market Drivers
    • 4.1.1 Rising Prevalence of Genetic Diseases in North America
    • 4.1.2 Rise in Awareness & Acceptance of Personalized Medicines
  • 4.2 Key Market Restraints
  • 4.3 Social and Ethical Implications of Genetic Testing
  • 4.4 Key Market Opportunities
    • 4.4.1 Growing Preference towards Direct-To-Consumer (DTC) Genetic Testing in North America
  • 4.5 Future Trends
    • 4.5.1 Artificial Intelligence (AI) Powered Genetic Testing
  • 4.6 Impact Analysis Of Drivers And Restraints

5. Genetic Testing Services Market - North America Analysis

  • 5.1 North America Genetic Testing Services Market Revenue Forecasts And Analysis
  • 5.2 Market Positioning
  • 5.3 Performance Of Key Players
    • 5.3.1 Thermo Fischer Scientific Inc.,
    • 5.3.2 F. Hoffmann-La Roche Ltd
    • 5.3.3 Illumina, Inc.

6. North America Genetic Testing Services Market Analysis - By Type

  • 6.1 Overview
  • 6.2 North America Genetic Testing Services Market, By Type, 2019 & 2027 (%)
  • 6.3 North America Genetic Testing Services Market Revenue And Forecasts To 2027, By Type (Us$ Mn)
  • 6.4 New-born Screening Market
    • 6.4.1 Overview
    • 6.4.2 New-born Screening Market Revenue and Forecast to 2027 (US$ Mn)
  • 6.5 Prenatal Testing Market
    • 6.5.1 Overview
    • 6.5.2 Prenatal Testing Market Revenue and Forecast to 2027 (US$ Mn)
  • 6.6 Predictive Testing Market
    • 6.6.1 Overview
    • 6.6.2 Predictive Testing Market Revenue and Forecast to 2027 (US$ Mn)
  • 6.7 Carrier Testing Market
    • 6.7.1 Overview
    • 6.7.2 Carrier Testing Market Revenue and Forecast to 2027 (US$ Mn)
  • 6.8 Other Testing's Market
    • 6.8.1 Overview
    • 6.8.2 Other Testing's Market Revenue and Forecast to 2027 (US$ Mn)

7. North America Genetic Testing Services Market Analysis - By Disease

  • 7.1 Overview
  • 7.2 North America Genetic Testing Services Market, By Disease, 2019 & 2027 (%)
  • 7.3 North America Genetic Testing Services Market Revenue And Forecasts To 2027, By Disease (Us$ Mn)
  • 7.4 Cancer Market
    • 7.4.1 Overview
    • 7.4.2 Cancer Market Revenue and Forecast to 2027 (US$ Mn)
  • 7.5 Metabolic Diseases Market
    • 7.5.1 Overview
    • 7.5.2 Metabolic Diseases Market Revenue and Forecast to 2027 (US$ Mn)
  • 7.6 Cardiovascular Disease Market
    • 7.6.1 Overview
    • 7.6.2 Cardiovascular Disease Market Revenue and Forecast to 2027 (US$ Mn)
  • 7.7 Other Diseases Market
    • 7.7.1 Overview
    • 7.7.2 Other Diseases Market Revenue and Forecast to 2027 (US$ Mn)

8. North America Genetic Testing Services Market Analysis - By Service Provider

  • 8.1 Overview
  • 8.2 North America Genetic Testing Services Market, By Service Provider, 2019 & 2027 (%)
  • 8.3 North America Genetic Testing Services Market Revenue And Forecasts To 2027, By Disease (Us$ Mn)
  • 8.4 Diagnostic Laboratories Market
    • 8.4.1 Overview
    • 8.4.2 Diagnostic Laboratories Market Revenue and Forecast to 2027 (US$ Mn)
  • 8.5 Hospital-Based Laboratories Market
    • 8.5.1 Overview
    • 8.5.2 Hospital-Based Laboratories Market Revenue and Forecast to 2027 (US$ Mn)
  • 8.6 Clinics Market
    • 8.6.1 Overview
    • 8.6.2 Clinics Market Revenue and Forecast to 2027 (US$ Mn)

9. North America Genetic Testing Services Market Revenue And Forecasts To 2027

  • 9.1 Overview
  • 9.2 North America Genetic Testing Services Market Revenue And Forecasts To 2027, By Country (%)
    • 9.2.1 US Genetic Testing Services Market Revenue and Forecasts to 2027 (US$ Mn)
    • 9.2.2 US Genetic Testing Services Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.2.2.1 US Genetic Testing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
      • 9.2.2.2 US Genetic Testing Services Market Revenue And Forecasts to 2027, By Disease (US$ Mn)
      • 9.2.2.3 US Genetic Testing Services Market, Revenue and Forecast to 2027, by Service Provider (US$ Mn)
    • 9.2.3 Canada Genetic Testing Services Market Revenue and Forecasts to 2027 (US$ Mn)
    • 9.2.4 Canada Genetic Testing Services Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.2.4.1 Canada Genetic Testing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
      • 9.2.4.2 Canada Genetic Testing Services Market Revenue And Forecasts to 2027, By Disease (US$ Mn)
      • 9.2.4.3 Canada Genetic Testing Services Market Revenue And Forecasts to 2027, By Service Provider (US$ Mn)
    • 9.2.5 Mexico Genetic Testing Services Market Revenue and Forecasts to 2027 (US$ Mn)
    • 9.2.6 Mexico Genetic Testing Services Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.2.6.1 Mexico Genetic Testing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
      • 9.2.6.2 Mexico Genetic Testing Services Market Revenue And Forecasts to 2027, By Disease (US$ Mn)
      • 9.2.6.3 Mexico Genetic Testing Services Market Revenue And Forecasts to 2027, By Service Provider (US$ Mn)

10. Genetic Testing Services Market -Industry Landscape

  • 10.1 Overview
  • 10.2 Growth Strategies In The Genetic Testing Services Market, 2017-2020
  • 10.3 Organic Developments
    • 10.3.1 Overview
    • 10.3.2 Organic Growth Strategies In The Genetic Testing Services Market, 2017-2020
  • 10.4 Inorganic Developments
    • 10.4.1 Overview
    • 10.4.2 Inorganic Growth Strategies In The Genetic Testing Services Market, 2017-2020

11. Genetic Testing Services Market- Key Company Profiles

  • 11.1 Laboratory Corporation of America Holdings
    • 11.1.1 Key Facts
    • 11.1.2 Business Description
    • 11.1.3 Products and Services
    • 11.1.4 Financial Overview
    • 11.1.5 SWOT Analysis
    • 11.1.6 Key Developments
  • 11.2 F. HOFFMANN-LA ROCHE LTD
    • 11.2.1 Key Facts
    • 11.2.2 Business Description
    • 11.2.3 Products and Services
    • 11.2.4 Financial Overview
    • 11.2.5 SWOT Analysis
    • 11.2.6 Key Developments
  • 11.3 Illumina, Inc.
    • 11.3.1 Key Facts
    • 11.3.2 Business Description
    • 11.3.3 Products and Services
    • 11.3.4 Financial Overview
    • 11.3.5 SWOT Analysis
    • 11.3.6 Key Developments
  • 11.4 Quest Diagnostics Incorporated
    • 11.4.1 Key Facts
    • 11.4.2 Business Description
    • 11.4.3 Products and Services
    • 11.4.4 Financial Overview
    • 11.4.5 SWOT Analysis
    • 11.4.6 Key Developments
  • 11.5 Exact Sciences Corporation
    • 11.5.1 Key Facts
    • 11.5.2 Business Description
    • 11.5.3 Products and Services
    • 11.5.4 Financial Overview
    • 11.5.5 SWOT Analysis
    • 11.5.6 Key Developments
  • 11.6 NeoGenomics Laboratories, Inc.
    • 11.6.1 Key Facts
    • 11.6.2 Business Description
    • 11.6.3 Products and Services
    • 11.6.4 Financial Overview
    • 11.6.5 SWOT Analysis
    • 11.6.6 Key Developments
  • 11.7 Eurofins Scientific
    • 11.7.1 Key Facts
    • 11.7.2 Business Description
    • 11.7.3 Products and Services
    • 11.7.4 Financial Overview
    • 11.7.5 SWOT Analysis
    • 11.7.6 Key Developments
  • 11.8 Ambry Genetics
    • 11.8.1 Key Facts
    • 11.8.2 Business Description
    • 11.8.3 Products and Services
    • 11.8.4 Financial Overview
    • 11.8.5 SWOT Analysis
    • 11.8.6 Key Developments
  • 11.9 Centogene AG
    • 11.9.1 Key Facts
    • 11.9.2 Business Description
    • 11.9.3 Products and Services
    • 11.9.4 Financial Overview
    • 11.9.5 SWOT Analysis
    • 11.9.6 Key Developments
  • 11.10andMe, Inc.
    • 11.10.1 Key Facts
    • 11.10.2 Business Description
    • 11.10.3 Products and Services
    • 11.10.4 Financial Overview
    • 11.10.5 SWOT Analysis
    • 11.10.6 Key Developments
  • 11.11 THERMO FISHER SCIENTIFIC INC.
    • 11.11.1 Key Facts
    • 11.11.2 Business Description
    • 11.11.3 Products and Services
    • 11.11.4 Financial Overview
    • 11.11.5 SWOT Analysis
    • 11.11.6 Key Developments

12. Appendix

  • 12.1 About The Insight Partners
  • 12.2 Glossary Of Terms
  • 12.3 Methodology
    • 12.3.1 Coverage
    • 12.3.2 Secondary Research
    • 12.3.3 Primary Research
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.